Studies on radiotherapy cost-effectiveness in the treatment of lung cancer have been carried out both in the European and in the Belgian context. A large comparative study published in 2020 in the Lancet Oncology Review shows annual expenditure for Belgian radiotherapy corresponding to 6.4% of the overall expenditure of the total oncology budget, lower than the European average of 7.8%.
« Go back